KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Overview Fund Activity
Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

85 hedge funds and large institutions have $95.6M invested in Chinook Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
-2
Holders Change %
-2.3%
% of All Funds
1.9%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
32
Reduced
23
Closed
18
Calls
$99K
Puts
$3K
Net Calls
+$96K
Net Calls Change
-$4K

Top Buyers

1
FLAM
First Light Asset Management
Minnesota
+$9.42M
2
Citadel Advisors
Citadel Advisors
Florida
+$1.88M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$1.54M
4
AG
Artal Group
Luxembourg
+$1.19M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.09M

Top Sellers

1
ACM
Aquilo Capital Management
California
-$15.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$13.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.04M
4
VIA
Vident Investment Advisory
Georgia
-$2.24M
5
BI
BVF Inc
California
-$2.12M
Name Holding Trade Value Shares
Change 		Shares
Change %
SPIA
101
Steward Partners Investment Advisory
New York
– -$8K -220 Closed
CF
102
Centaurus Financial
California
– -$624 -17 Closed
1 2 3 4
5